Praluent vs. Livalo

See how Praluent and Livalo compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Praluent is an injectable PCSK9 inhibitor dosed every 2 or 4 weeks, while Livalo is a daily oral statin tablet.

  • Praluent is FDA-approved to lower the risk of heart attack, stroke, and hospitalization for unstable angina in adults with existing cardiovascular disease, a use not included on Livalo's label.

  • Livalo is typically tried first for high cholesterol because it's a pill, while Praluent is often added when statins alone aren't enough or aren't tolerated.

Praluent vs. Livalo Drug Summary

Praluent

Praluent is a PCSK9 inhibitor, an injectable antibody drug that lowers LDL cholesterol by helping the liver clear it from the blood. It's given as a self-administered shot under the skin every 2 or 4 weeks, usually alongside diet and statin therapy or on its own for people with certain heart conditions.

Livalo

Livalo is a statin, an oral pill that lowers LDL cholesterol by blocking an enzyme the liver uses to make it. It's taken once daily, with or without food, and is often the first medication tried for high cholesterol before injectable options are considered.

Praluent vs. Livalo Side Effects

Praluent

Most common
nasopharyngitis (up to 11.3%)
injection site reactions (up to 7.2%)
influenza (up to 5.7%)
urinary tract infection (up to 4.8%)

Livalo

Most common
myalgia (1.9% to 3.1%)
constipation (1.5% to 3.6%)
diarrhea (1.5% to 2.6%)
back pain (1.4% to 3.9%)

Praluent vs. Livalo Dosage

Praluent

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 75 mg every 2 weeks At the start
Maximum dose 300 mg every 4 weeks If needed
Dose changes 2 increases As tolerated

Livalo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 4 mg once daily If needed
Dose changes 2 increases As tolerated

Praluent vs. Livalo Indications

Praluent

Praluent is approved to lower LDL cholesterol in adults on maximally tolerated statin therapy, to treat heterozygous familial hypercholesterolemia in people 8 and older, and to reduce the risk of heart attack, stroke, and hospitalization for unstable angina in adults with existing cardiovascular disease. It is not approved for homozygous familial hypercholesterolemia or for children under 8.

  • Add-on to statins for high LDL cholesterol

  • Heterozygous familial hypercholesterolemia (age 8+)

  • Reduces cardiovascular event risk in heart disease

  • Not approved for homozygous FH

Livalo

Livalo is approved as an add-on to diet to lower LDL cholesterol, total cholesterol, apolipoprotein B, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and to lower LDL in heterozygous familial hypercholesterolemia in adults and children 8 and older. It is sometimes used off-label for primary prevention of atherosclerotic cardiovascular disease.

  • Add-on to diet for high LDL cholesterol

  • Heterozygous familial hypercholesterolemia (age 8+)

  • Lowers triglycerides and apolipoprotein B

  • Off-label: primary ASCVD prevention

Praluent vs. Livalo Pros and Cons

Praluent

Praluent offers proven cardiovascular event reduction and flexible dosing intervals, but it requires self-injection and has no generic alternative, which keeps its list price high. Insurance coverage often requires trying and failing statins first.

Pros

  • Proven to reduce heart attack and stroke risk

  • Dosing as infrequent as once every 4 weeks

  • Works for people who can't tolerate statins

  • Approved for HeFH down to age 8

Cons

  • Requires self-injection, not a pill

  • No generic or biosimilar version available

  • Roughly $500 to $640 per month without insurance, before savings programs

Livalo

Livalo is a well-tolerated statin with minimal drug interactions and decades of safety data, but it lacks Praluent's proven reduction in heart attack and stroke risk. It's taken daily as a pill, which many people find easier to manage than an injection.

Pros

  • Simple once-daily oral pill

  • Fewer drug interactions than many statins

  • Roughly $315 to $410 per month without insurance, before savings programs

  • Long safety track record since 2009

Cons

  • Not proven to reduce cardiovascular events

  • Myopathy and rhabdomyolysis risk at higher doses

  • Not approved for use during pregnancy

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.